Dr. Julie E. Buring is Professor of Medicine, Emerita at Harvard Medical School/Brigham and Women‘s Hospital, and Professor of Epidemiology, Emerita at the Harvard T.H. Chan School of Public Health.

The primary focus of Dr. Buring’s research has been the epidemiology of the prevention of chronic diseases, especially cardiovascular disease and cancer, and with a primary methodologic focus on the design, conduct, analysis, and interpretation of randomized clinical trials. Dr. Buring has served as principal investigator, multiple principle investigator, or co-investigator of a number of National Institutes of Health-funded large-scale randomized clinical trials and their observational follow-up, including: the Women’s Health Study, evaluating the balance of benefits and risks of low dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among 40,000 female health professionals; VITAL, evaluating vitamin D and fish oil in the primary prevention of cardiovascular disease and cancer among 26,000 participants from the general population; and the Physicians' Health Study, which evaluated the preventive roles of low-dose aspirin, beta-carotene, vitamin E, vitamin C, and a multivitamin on cardiovascular disease, cancer, vision, and cognitive function.

Dr. Buring has had a longstanding and substantial commitment to teaching and training in epidemiology, both nationally and internationally. She served as Chair of the Harvard Medical School’s Institutional Review Board (IRB) for over two decades.